Shanghai Haohai Biological Technology’s $40 Million Investment in Eirion Therapeutics

Martina Bellini
Tagged:

Locke Lord LLP advised Shanghai Haohai Biological Technology Co. on the deal.Shanghai Haohai Biological Technology Co., Ltd., a public company traded on the Hong Kong and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here